vk2735 vs tirzepatide Viking Therapeutics: Is 2026 the year? VK2735: Viking's Oral GLP-1 Weight

If your plan excludes Zepbound for weight loss, you still have options

NICE recommends them when metformin and other therapies are insufficient, particularly for patients with high BMI, cardiovascular disease, or chronic kidney disease

Though not common, GLP-1 medications can trigger or worsen gastroparesis in some individuals

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

Allulose is also commercially produced, although its not as commonly used as other sugars in packaged foods and beverages or as a tabletop sweetener